Publisert 23.01.2019

Board Meeting No. 1 2019

Board Meeting No. 1 2019

January 23rd 2019

Notice 

Protocol (draft not signed) 

Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.